Enzon Pharmaceuticals Files 8-K: Material Agreement & More
Ticker: ENZN · Form: 8-K · Filed: Apr 1, 2025 · CIK: 727510
Sentiment: neutral
Topics: material-agreement, corporate-action, filing
TL;DR
Enzon Pharma filed an 8-K on 3/31/25 for a material agreement. Big moves ahead?
AI Summary
On March 31, 2025, Enzon Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The filing also addresses modifications to security holder rights and includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing indicates significant corporate activity, potentially involving new agreements or changes affecting Enzon Pharmaceuticals' stakeholders.
Risk Assessment
Risk Level: medium — Material definitive agreements and modifications to security holder rights can introduce new risks or alter existing ones for investors.
Key Players & Entities
- Enzon Pharmaceuticals, Inc. (company) — Registrant
- March 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement filed by Enzon Pharmaceuticals, Inc. on March 31, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What other items are covered in this 8-K filing besides the material definitive agreement?
The filing also covers material modifications to the rights of security holders and includes financial statements and exhibits.
When is Enzon Pharmaceuticals, Inc.'s fiscal year end?
Enzon Pharmaceuticals, Inc.'s fiscal year ends on December 31.
What is the Commission File Number for Enzon Pharmaceuticals, Inc.?
The Commission File Number for Enzon Pharmaceuticals, Inc. is 001-36435.
What is the IRS Employer Identification Number for Enzon Pharmaceuticals, Inc.?
The IRS Employer Identification Number for Enzon Pharmaceuticals, Inc. is 22-2372868.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding ENZON PHARMACEUTICALS, INC. (ENZN).